Patents by Inventor Claire Fabre

Claire Fabre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230056470
    Abstract: Therapies using TGF-? inhibitors and/or PD-1 inhibitors are disclosed. These drugs at certain doses (including flat dosing) and regimens can be used to treat or prevent proliferative diseases such as solid tumors, including pancreatic cancers. Further combination and uses thereof are also disclosed.
    Type: Application
    Filed: December 3, 2020
    Publication date: February 23, 2023
    Inventors: Mirek DOSTALEK, Claire FABRE, Fariba KHANSHAN
  • Publication number: 20230057071
    Abstract: Combination therapies comprising TIM-3 inhibitors and TGF-? inhibitors are disclosed. The combinations can be used to treat or prevent cancerous conditions and disorders, including myelofibrosis or myelodysplastic syndrome.
    Type: Application
    Filed: December 3, 2020
    Publication date: February 23, 2023
    Inventors: K. Gary J. VANASSE, Haiying SUN, Mirek DOSTALEK, Mikael RINNE, Anshu MARATHE, Luigi MANENTI, Claire FABRE, Fariba KHANSHAN
  • Publication number: 20220281970
    Abstract: The present invention relates to the combination of the HDM2-p53 interaction inhibitor drug (S)-5-(5-Chloro-1-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-6-(4-chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one [HDM201] and an anti-TIM-3 antibody molecule as TIM-3 inhibitor. The present invention further relates to the use of said combination in the treatment of cancer, in particular hematological tumors. The present invention further relates to dose and dosing regimen related to this combination cancer treatment.
    Type: Application
    Filed: December 18, 2019
    Publication date: September 8, 2022
    Inventors: Nelson Guerreiro, Ensar Halilovic, Astrid Jullion, Christophe Meille, Hui-Qin Wang, Claire Fabre
  • Publication number: 20220031697
    Abstract: The present invention relates to the HDM2-p53 interaction inhibitors (S)-5-(5-Chloro-1-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-6-(4-chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one (HDM201), or a pharmaceutically acceptable non-covalent derivative thereof, for use in the treatment of patients with hematological tumors, wherein the drug is administered by an extended low dose dosing regimen.
    Type: Application
    Filed: August 13, 2021
    Publication date: February 3, 2022
    Inventors: Stephane FERRETTI, Nelson GUERREIRO, Sebastien JEAY, Astrid JULLION, Christophe MEILLE, Jens WUERTHNER, Claire Fabre
  • Patent number: 4689237
    Abstract: A process for heating a fluid, such as a foodstuff, by passing a vapor at a high temperature and under pressure through an annular chamber extending around a perforated mixing chamber and injecting the vapor from the annular chamber into the mixing chamber perpendicularly to the fluid flowing through the mixing chamber. A stream of the fluid, vapor and vapor-fluid mixture thus obtained is passed through and out from the mixing chamber into the constricting means of an axial nozzle having a passage means. The stream is then passed through the passage means in axial extension with the constricting means for producing complete condensation of the vapor in the stream so as to increase the fluid temperature, thereby generating cavitation in the vicinity of a point of maximum constriction of the stream located inside the passage means to produce a critical flow therein.
    Type: Grant
    Filed: July 13, 1984
    Date of Patent: August 25, 1987
    Assignee: Institute National de la Recherche Agronomique
    Inventor: Claire Fabre